Press "Enter" to skip to content

New patent for Gilead Sciences drug VOSEVI

0
Copyright © DrugPatentWatch. Originally published at New patent for Gilead Sciences drug VOSEVI

Annual Drug Patent Expirations for VOSEVI
Annual Drug Patent Expirations for VOSEVI

Vosevi is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are seventeen patents protecting this drug.

Drug patent litigation for VOSEVI.

This drug has two hundred and sixty-one patent family members in forty-seven countries.

The generic ingredient in VOSEVI is sofosbuvir; velpatasvir; voxilaprevir. One supplier is listed for this compound. Additional details are available on the sofosbuvir; velpatasvir; voxilaprevir profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Gilead Sciences drug VOSEVI
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions